Skip to main content

Peer Review reports

From: Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients – study protocol for a randomized controlled trial

Original Submission
12 Feb 2018 Submitted Original manuscript
31 Mar 2018 Reviewed Reviewer Report - Hongxia Ma
3 Apr 2018 Reviewed Reviewer Report - Scott Garrison
3 Apr 2018 Reviewed Reviewer Report - Patrizia Pasanisi
26 Jul 2018 Author responded Author comments - Alexandra Halalau
Resubmission - Version 2
26 Jul 2018 Submitted Manuscript version 2
Publishing
2 Aug 2018 Editorially accepted
24 Aug 2018 Article published 10.1186/s13063-018-2836-8

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215